Crossmark

The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future

Crossref DOI link: https://doi.org/10.1007/s40268-018-0230-3

Published Online: 2018-03-15

Published Print: 2018-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Auffret, Manon http://orcid.org/0000-0002-7003-4084
Drapier, Sophie

Vérin, Marc
License Information

Text and Data Mining valid from 2018-03-15
More Information

Article History

First Online: 15 March 2018

Change Date: 8 May 2018

Change Type: Correction

Change Details: In the original publication, the name of the author in T.

Compliance with Ethical Standards

:

: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

: The authors declare that there are no conflicts of interest relevant to this work.

: Dr. Manon Auffret: none. Dr. Sophie Drapier served on scientific advisory boards for Orkyn and Aguettant, received speech honorarium from Orkyn, Aguettant, Medtronic, and Teva, and received PHRC grants from the French Ministry of Health (unrelated to this article). Prof. Marc Vérin served on scientific advisory boards for Orkyn and Aguettant and received speech honorarium from Orkyn, Aguettant, Medtronic, and Teva (unrelated to this article).